Zobo, promising weapon against drug-resistant UTI bacteria, experts say

Researchers at the Federal University Dutsin-Ma have found that Hibiscus sabdariffa (Zobo) extracts show promise in inhibiting multidrug-resistant E. coli. This study highlights a potential natural alternative to antibiotics for treating urinary tract infections.
Why it matters
As antimicrobial resistance grows, identifying natural, accessible antimicrobial agents is critical for public health in developing nations.
Add as a preferred source Researchers at the Federal University Dutsin-Ma (FUDMA), Katsina State, have identified Hibiscus sabdariffa, popularly known as Zobo, as a promising natural antimicrobial agent against multidrug-resistant Escherichia coli (E. coli), the leading cause of urinary tract infections (UTIs).
In a new study, the researchers demonstrated that both aqueous and ethanol extracts of Hibiscus sabdariffa inhibited the growth of multidrug-resistant E. coli, with the antibacterial activity increasing as the concentration of the extracts increased.
The findings, published in the Asian Journal of Biotechnology and Genetic Engineering, come at a time when Nigeria and many other countries are grappling with the growing threat of antimicrobial resistance, which has reduced the effectiveness of several commonly prescribed antibiotics.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in